ACS Dobfar is a privately held, chemical-pharmaceutical company that offers high quality pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms (oral and injectables). The company is committed to the production of Beta-lactam and Non Beta-lactam Anti-infectives, in particular Cephalosporins, Carbapenems, and Penicillins. It exports its products to more than 100 countries and employs more than 900 workers distributed over 6 production sites. ACS Dobfar was founded on 1973 and is headquartered in Agrate Brianza, Italy.

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Suzhou Shengda Pharmaceutical Co., Ltd., established on 1998-11-10, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Drug import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;Non-residential real estate leases;market survey(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Wockhardt Ltd. is a Global pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It is a global company with more than half of its revenue coming from Europe. In 2011–2012 its UK and USA sales alone were US$475 million. It has market presence in emerging markets such as Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait. The Company has a market capitalisation of over ₹211 billion (US$3.1 billion) and an annual turnover of ₹36 billion (US$520 million). It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients (APIs). The company employs over 8,600 people globally. Wockhardt Hospitals is a subsidiary of the Wockhardt Group.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Tianjin Harmony Biotechnology Co., Ltd., established on 2002-07-26, Business scope includes new drug technology development,And provide related technology transfer and technical consulting services(No country restrictions,Prohibited items;Involved in the management of industry authorities,Approval from relevant industry departments must be obtained before proceeding);Chemical Products(Hazardous chemicals and flammable and explosive precursors are excluded)Wholesale and retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hainan Huluwa Pharmaceutical Group Co. Ltd. engages in the research and development, production, and sales of proprietary Chinese medicines and chemical reagent. Its product application covers respiratory system, digestive system, and systemic anti-infective. The company was founded on June 22, 2005 and is headquartered in Haikou, China.

Shionogi & Co., Ltd. engages in the research, development, supply, manufacture and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.

Lemonex Co., Ltd.is engaged in developing and commercializing cancer immunotherapeutic, antibody therapeutics and gene therapeutics. The company was founded on December 17, 2013 and is headquartered in Seoul, South Korea.

Suzhou No. 3 Pharmaceutical Factory Co., Ltd., established on 1981-12-14, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug retail;Drug import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Specialty Chemicals Sales(Free of Hazardous Chemicals);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Research and Experimental Development;market survey(Does not include foreign investigations)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

ChemGenex Pharmaceuticals, Inc. manufactures and develops pharmaceuticals. It develops novel protein, antibody, & small molecule therapeutics in the areas of oncology, obesity, diabetes, and central nervous system disorders. The company is a subsidiary of Chemgenex Pharmaceuticals Ltd. It was founded in 2004 and is headquartered in Menlo Park, CA.

AMRI (Albany Molecular Research Inc.) is a contract research and manufacturing organization that provides drug discovery, development, cGMP manufacturing and aseptic fill and finish to the pharmaceutical and biotechnology industries. Founded over 27 years ago, AMRI operates in the United States, Europe and Asia, with its headquarters located in Albany, New York. AMRI has announced deals and collaborations with such companies as Pfizer Inc., Merck & Co., Eli Lilly and Co., Takeda, Genentech, Bristol-Myers Squibb Co. and GE.

Jiangsu Aogam Biotechnology Co., Ltd., established on 2012-05-15, Business scope includes medical devices(Operate according to the scope listed in the license);Office Supplies,Daily necessities,Electronics and Accessories,Computer Supplies Sales;Computer software and hardware development and maintenance;Self-operated and agent import and export of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of);Housekeeping;Research and development of biotechnology and products,technology transfer,Technical extension services;Medical device technical consultation.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.

Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.

Hangzhou Changdian Laoyiyuan Health Management Co., Ltd., established on 2008-11-03, Business scope includes services:Non-medical health management consulting services,Economic Information Consulting(ex-securities,futures),marketing planning,Corporate Affairs Agency,Tendering agent,Conference services and hosting exhibitions,Promotion of medical technology;technology R & D,Technical Services,technology transfer,technical consulting:medical instruments,medical technology,Product Traceability System(except medical services);Sales:cosmetic,daily necessities,electronic product(Except for electronic publications);Marketing Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Achaogen is a clinical stage biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat multi-drug resistant bacterial infections. The company's most advanced drug candidate, ACHN-490, has demonstrated a positive safety and dosing profile in Phase 1 clinical testing and displayed broad spectrum efficacy in preclinical studies against systemic infections caused by multi-drug resistant (MDR) Gram-negative bacteria (e.g., E. coli, K. pneumoniae, and P. aeruginosa) and MRSA. In addition, the company is pursuing preclinical programs in several other areas of interest to combat the global emergence of bacterial resistance.

Jiangxi Yukang Pharmaceutical Co., Ltd., established on 2015-07-29, Business scope includes licensed projects:Drug Wholesale,Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Sales of Class I Medical Devices,Sales of Class II Medical Devices,food sales(Only sell prepackaged food),Healthy food(prepackaged)Sales,Disinfectant sales(Free of Hazardous Chemicals),Cosmetics Wholesale,General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval),Low temperature storage(Does not contain hazardous chemicals and other items that require approval),Purchase of primary agricultural products,Sales of agricultural and sideline products,Business Management Consulting,Health Consulting Services(Does not include medical services),marketing planning,Information Consulting Service(Not including licensing information consulting services),Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Conference and Exhibition Services(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)